Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I studyShunji Takahashi, Noboru Yamamoto, Yasuyuki Kakurai et al.|Cancer Science|2021Cited by 72
Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer centerKoichi Takeda, Daisuke Ohkushi, Brian Hayama et al.|BMC Cancer|2021Cited by 28
Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumorSohei Harada, Brian Hayama, Katsuhiko Kamei et al.|Journal of Infection and Chemotherapy|2019Cited by 10